0001209191-23-031243.txt : 20230519 0001209191-23-031243.hdr.sgml : 20230519 20230519184818 ACCESSION NUMBER: 0001209191-23-031243 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230517 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schneyer Mark C. CENTRAL INDEX KEY: 0001899977 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 23941971 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 12830 EL CAMINO REAL, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-17 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001899977 Schneyer Mark C. C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130 0 1 0 0 EVP, Chief Financial Officer 0 Common Stock 2023-05-17 4 M 0 14869 A 22346 D Common Stock 2023-05-17 4 M 0 14869 A 37215 D Common Stock 2023-05-17 4 S 0 15310 22.50 D 21905 D Restricted Stock Units 2023-05-17 4 M 0 14869 0.00 D Common Stock 14869 24782 D Restricted Stock Units 2023-05-17 4 M 0 14869 0.00 D Common Stock 14869 24782 D Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period. /s/ Austin D. Kim, Attorney-in-Fact 2023-05-19